A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC).
暂无分享,去创建一个
F. Greco | R. Birch | T. Goggins | C. Hagenstad | R. T. Webb | N. Mehta | W. Khan | J. Allerton | S. Katakkar | G. B. Smith